Extracting value from dark biodiversity: a 6-step process
Recent advances in genomic sequencing and cultivation technologies have revealed the existence of a microbial dark matter but to date this new “domain of life” is largely unexplored and much less exploited. To extract value from this hidden biodiversity, DEINOVE has implemented a 6-step R&D process that covers from microbiological investigations to the clinical proof of concept of antimicrobial candidates. At each step, the company mobilizes all or part of its technological units and its world-class network of academic and industrial partners.
Extracting microbial biodiversity
Reveal, tame and safeguard the hidden micro-organisms
Active compound identification & characterization
From the complex bacterial extract to the active molecule
Preindustrial production of the drug candidate
Optimizing the synthesis of rare, low-concentrated and complex chemical compounds
Preclinical and clinical development
Transferring the best of biodiversity from lab to patient’s bedside